Tevogen (TVGN) Interest Coverage Ratio (2023 - 2025)
Tevogen's (TVGN) quarterly Interest Coverage Ratio came in at 421.49 in Q1 2025, down 122.46% on a YoY basis from 1876.95 in Q1 2024, and up 28.89% quarter-over-quarter from 592.68 in Q4 2024.
Analysis
Tevogen (TVGN) Interest Coverage Ratio (2023 - 2025) Analysis & Trends
Tevogen (TVGN) has reported Interest Coverage Ratio for 3 consecutive years, with 421.49 the latest figure, recorded in Q1 2025.
- For the quarter ending Q1 2025, Interest Coverage Ratio fell 122.46% year-over-year to 421.49; the trailing twelve-month figure through Mar 2025 stood at 164.92 (down 386.14% YoY), and the FY2024 full-year result was 291.05, down 3870.5% from the prior year.
- Interest Coverage Ratio rose to 421.49 in Q1 2025 per TVGN's latest filing, from 592.68 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 6.33 in Q4 2023 and bottomed at 592.68 in Q4 2024.
- Historically, Interest Coverage Ratio has averaged 244.89 across 3 years, with a median of 189.47 in 2024.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio slumped 9266.18% in 2024, then sank 122.46% in 2025.
- Over 3 years, Interest Coverage Ratio stood at 6.33 in 2023, then plunged by 9266.18% to 592.68 in 2024, then gained by 28.89% to 421.49 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 421.49, 592.68, and 488.44 for Q1 2025, Q4 2024, and Q3 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | -0.01 |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 9.95 |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | -3.63 |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 7.67 |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 2.71 |
| 10 | Tevogen | 27.76 Mn | 27.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -421.49 |
| Dec 31, 2024 | -592.68 |
| Sep 30, 2024 | -488.44 |
| Mar 31, 2024 | -189.47 |
| Dec 31, 2023 | -6.33 |
| Sep 30, 2023 | -7.75 |
| Mar 31, 2023 | -8.04 |